- Home
- GNS vs ONMD Comparison
GNS vs ONMD Comparison
Compare GNS & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNS | ONMD |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | 23 |
| Industry | Other Consumer Services | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.7M | 56.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNS | ONMD |
|---|---|---|
| Price | $0.23 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 14.3M | 292.0K |
| Earning Date | 03-09-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $156.26 | N/A |
| Revenue Next Year | $35.38 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.34 |
| 52 Week High | $1.92 | $4.22 |
Technical Indicators
Market Signals| Indicator | GNS | ONMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.30 | 37.87 |
| Support Level | $0.21 | $0.59 |
| Resistance Level | $0.48 | $0.96 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 26.93 | 34.53 |
Price Performance
Historical ComparisonAbout GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.